作者:Wankhede, Sonal、Kumar, Nitesh、Simon, Lalitha、Biswas, Subhankar、Gourishetti, Karthik、Ramalingayya, Grandhi Venkata、Joshi, Mit、Rao, C. Mallikarjuna
DOI:10.17179/excli2017-624
日期:——
tumors (50 mg/kg MNU i.p.) were grouped in four, namely MNU control (0.25 % of CMC p.o.), standard group (doxorubicin 2 mg/kg once in 4 days, i.p.), C1 and C2 groups (50 mg/kg p.o. each). After 21 days of treatments, tumor volume and weight were assessed. Excised tumors were subjected to DNA fragmentation study. MTT assay showed IC50 values of 62.56 and 37.8 µM by for C1 and C2. Both compounds increased
通过克莱森-施密特缩合法合成了两个5'乙酰氨基查耳酮C1和C2,并通过IR,LC-MS,1H NMR和13C NMR进行了表征。使用MTT分析,抗转移分析,AO / EB染色进行凋亡筛选以及在N-甲基-N体内体内评估这些化合物在乳腺癌细胞系(MCF-7和MDA-MB-231)中的体外抗癌活性-亚硝基脲(MNU)诱导的乳腺癌模型。将患有肿瘤(50 mg / kg MNU腹膜内)的Sprague-Dawley大鼠分为四个组,即MNU对照(CMC po的0.25%),标准组(阿霉素2 mg / kg,每4天一次,腹膜内),C1和C2各组(每个口服50 mg / kg)。治疗21天后,评估肿瘤的体积和重量。对切除的肿瘤进行DNA断裂研究。MTT分析显示,C1和C2的IC50值为62.56和37.8 µM。与AO / EB染色的正常对照相比,这两种化合物均能使凋亡小体增加3倍以上。与正常对照相比